Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Solid Malignancies × Rabeprazole × 1 year × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Neoplasms 1 Lung Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, B-Cell 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Solid Malignancies 1

Interventions

Injections 2 pembrolizumab 1 atezolizumab 1 Tiragolumab 1 Rosuvastatin Calcium 1 Radiotherapy 1 Rabeprazole 1 Metformin 1 Furosemide 1 Digoxin 1 ATP Binding Cassette Transporter, Subfamily B, Member 1 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06899061 2026-03-03

Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib

AstraZeneca

Phase 1 Active not recruiting

Advanced Solid Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡